Tirzepatide for Obesity and Meth Use Disorder

Clinical trial NCT06745128 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06745128
Sponsor: University of Texas Southwestern Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Obesity Methamphetamine Use Disorder

Start date: 2025-02-03
Primary completion: 2026-03-31
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.